Innovating for GrowthDr Emma Sceats,

Chief Executive, CN Bio Innovations

London, September 7th 2017

2

CASH

CUSTOMERS

COMMUNITY

3

OUR Vision

To be the world leader in precision biology

replacing animal testing with accurate,

human relevant technologies

4

$26m DARPA contract with the Massachusetts Institute of Technology

a Human-on-a-Chip?

5

Benefits

Intellectual Property

IP Pipeline

CN Bio secured exclusive rights to commercialise all IP arising from the MIT-led DARPA consortium’s research to develop a human body-on-a-chip.

Team

Recruiting new skills

DARPA grant enabled CN Bio to hire new team members bringing specialist biology and engineering skills into our business.

Expert Collaborators

MIT Professor Linda Griffith

Professor of Biological & Mechanical engineering. Lead PI on $26M DARPA contract. US National Academy of Engineers. Recipient of MacArthur “Genius” Fellowship.

6

“Ensuring that Britain remains attractive for inward investment will surely help more companies like ours access the funding needed for growth”

E. Sceats

7

8

Customers (early adopters)

Federal Grants & Contracts

Exports

Knowledge / IP

$$$

- Talent- Customers- Collaborators- Grants

9

“As small companies endeavour to become large and internationally successful businesses

understanding the challenges and trade-offs these businesses face

will be crucial for developing policies that will nurture home-grown talent”

E. Sceats

10

Ecosystem

TWO global Big Pharma companies (AZ, GSK) headquartered in UK

Thriving biotech sector from large, international players (e.g. Shire) to university spin-outs

World-class medical devices sector employing >50,000 staff

UK life sciences sector employs >233,000 people, generating £64bn revenue each year

#1 destination for foreign direct investment in Europe

11

“It will be exciting to see how implementation of Sir John Bell’s recommendations can be a catalyst for growth, both for our company and our country”

E. Sceats

12

Thank You